Abstract
Although hepatitis C virus (HCV) infection is very common, identification of patients during acute infection is rare. Consequently, little is known about the immune response during this critical stage of the disease. We analyzed the T lymphocyte response during and after acute resolving HCV infection in three persons, using interferon (IFN)-γ enzyme-linked immunospot (ELISPOT) and human histocompatibility leukocyte antigen (HLA) peptide tetramer assays. Acute infection was associated with a broadly directed T helper and cytotoxic T lymphocyte (CTL) response, which persisted after resolution of clinical hepatitis and clearance of viremia. At the earliest time point studied, highly activated CTL populations were observed that temporarily failed to secrete IFN-γ, a “stunned” phenotype, from which they recovered as viremia declined. In long-term HCV-seropositive persons, CTL responses were more common in persons who had cleared viremia compared with those with persistent viremia, although the frequencies of HCV-specific CTLs were lower than those found in persons during and after resolution of acute HCV infection. These studies demonstrate a strong and persistent CTL response in resolving acute HCV infection, and provide rationale to explore immune augmentation as a therapeutic intervention in chronic HCV infection.
Bibliography
Lechner, F., Wong, D. K. H., Dunbar, P. R., Chapman, R., Chung, R. T., Dohrenwend, P., Robbins, G., Phillips, R., Klenerman, P., & Walker, B. D. (2000). Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus. The Journal of Experimental Medicine, 191(9), 1499â1512.
References
63
Referenced
1,012
10.1126/science.285.5424.26
/ Science. / The scientific challenge of hepatitis C virus by Cohen (1999)10.1172/JCI118287
/ J. Clin. Invest. / HLA class I–restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release by Koziel (1995)10.1128/jvi.70.10.7092-7102.1996
/ J. Virol. / Differential CTL responsiveness to hepatitis B and C viruses in chronically infected patients by Rehermann (1996)10.1172/JCI118931
/ J. Clin. Invest. / Quantitative analysis of the peripheral blood CTL response in patients with chronic HCV infection by Rehermann (1996)10.1172/JCI117694
/ J. Clin. Invest. / CTL response to HCV-derived peptides containing the HLA-A2.1 binding motif by Cerny (1995)10.1002/eji.1830250248
/ Eur. J. Immunol. / Induction in vitro of a primary human antiviral cytotoxic T cell response by Cerny (1995)10.1002/hep.510250336
/ Hepatology. / Cytotoxic T lymphocyte response and viral load in hepatitis C virus infection by Hiroishi (1997)10.4049/jimmunol.160.3.1479
/ J. Immunol. / Liver-derived CTL in hepatitis C virus infectionbreadth and specificity of responses in a cohort of persons with chronic infection by Wong (1998)10.1006/viro.1998.9401
/ Virology. / Inefficient recognition of autologous viral sequences by intrahepatic HCV-specific CTL in chronically infected subjects by Giuggio (1998)10.1073/pnas.96.10.5692
/ Proc. Natl. Acad. Sci. USA. / Quantitative analysis of HCV-specific CD8+ T cells in peripheral blood and liver using peptide-MHC tetramers by He (1999)10.1128/jvi.68.7.4650-4655.1994
/ J. Virol. / Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome by Koup (1994)10.1089/aid.1997.13.1375
/ AIDS Res. Hum. Retroviruses. / Early postinfection antiviral treatment reduces viral load and prevents CD4+ cell decline in HIV type 2-infected macaques by Watson (1997)10.1016/S0016-5085(99)70289-1
/ Gastroenterology. / Direct ex vivo analysis of hepatitis B virus-specific CD8+ T cells associated with the control of infection by Maini (1999)10.1056/NEJM199905273402114
/ N. Engl. J. Med. / Control of HIV despite the discontinuation of antiretroviral therapy by Lisziewicz (1999)10.1073/pnas.94.1.254
/ Proc. Natl. Acad. Sci. USA. / The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viraemia by Pantaleo (1997)10.1128/JVI.73.7.5509-5519.1999
/ J. Virol. / Lack of viral escape and defective in vivo activation of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes in rapidly progressive infection by Hay (1999)10.1016/S1074-7613(00)80295-2
/ Immunity. / Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes by Guidotti (1996)10.1128/jvi.71.4.3120-3128.1997
/ J. Virol. / Suppression of human immunodeficiency virus type 1 replication by CD8+ cellsevidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms by Yang (1997)10.1126/science.284.5415.825
/ Science. / Viral clearance without destruction of infected cells during acute HBV infection by Guidotti (1999)10.1055/s-2007-1007107
/ Semin. Liver Dis. / Cytokines in viral hepatitis by Koziel (1999)10.1073/pnas.94.13.6874
/ Proc. Natl. Acad. Sci. USA. / A critical role for neutralizing antibody-producing B cells, CD4+ cells and interferons in persistent infections of mice with LCMVimplications for adoptive immunotherapy of virus carriers by Planz (1997)10.1084/jem.188.12.2205
/ J. Exp. Med. / Viral immune evasion due to persistence of activated T cells without effector function by Zajac (1998)10.1016/S0140-6736(95)91691-1
/ Lancet. / Possible mechanism involving T lymphocyte response to NS3 in viral clearance in acute HCV infection by Diepolder (1995)10.1172/JCI118842
/ J. Clin. Invest. / Different clinical behaviors of acute HCV infection are associated with different vigor of the anti-viral T cell response by Missale (1996)10.1016/S1074-7613(00)80044-8
/ Immunity. / Analysis of a successful immune response against HCV by Cooper (1999)10.1084/jem.187.9.1383
/ J. Exp. Med. / Induction and exhaustion of lymphocytic choriomeningitis virus–specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I–peptide complexes by Gallimore (1998)10.1016/S1074-7613(00)80470-7
/ Immunity. / Counting antigen-specific CD8 T cellsa reevaluation of bystander activation during viral infection by Murali-Krishna (1998)10.1038/9525
/ Nat. Med. / Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients by Lee (1999)10.1089/aid.1994.10.1427
/ AIDS Res. Hum. Retroviruses. / A novel method for detection and ex vivo expansion of HIV type 1-specific cytolytic T lymphocytes by Lubaki (1994)10.1128/jvi.67.3.1385-1395.1993
/ J. Virol. / Expression and identification of hepatitis C virus polyprotein cleavage products by Grakoui (1993)10.1126/science.274.5284.94
/ Science. / Direct visualization and phenotypic analysis of virus-specific T lymphocytes in HIV-infected individuals by Altman (1996)10.1128/jvi.69.4.2462-2470.1995
/ J. Virol. / Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules by Battegay (1995)10.1084/jem.187.9.1395
/ J. Exp. Med. / Direct visualization of antigen-specific CD8+ T cells during the primary immune response to EBV in vivo by Callan (1998)10.1016/S0960-9822(98)70161-7
/ Curr. Biol. / Direct isolation, phenotyping and cloning of low-frequency antigen-specific cytotoxic T lymphocytes from peripheral blood by Dunbar (1998)10.1146/annurev.iy.11.040193.001241
/ Annu. Rev. Immunol. / Peptides naturally presented by MHC class I molecules by Rammensee (1993)10.1097/00002030-199603000-00023
/ AIDS. / Identification of a novel A-25 restricted epitope in a conserved region of p24 gag (positions 71–80) by Klenerman (1996)10.1084/jem.189.2.423
/ J. Exp. Med. / Migration kinetics and final destination of type 1 and type 2 CD8 effector cells predict protection against pulmonary virus infection by Cerwenka (1999)10.1038/362758a0
/ Nature. / Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells by Moskophidis (1993)10.1038/375148a0
/ Nature. / Serial triggering of many T cell receptors by a few peptide-MHC complexes by Valitutti (1995)10.1126/science.273.5271.104
/ Science. / T cell activation determined by TCR number and tunable thresholds by Viola (1996)10.1084/jem.186.10.1775
/ J. Exp. Med. / Quantitative contribution of CD4 and CD8 to T cell antigen receptor serial triggering by Viola (1997)10.1016/S1074-7613(00)80540-3
/ Immunity. / Coordinate regulation of complex T cell populations responding to bacterial infection by Busch (1998)10.1016/S0016-5085(99)70353-7
/ Gastroenterology. / Recurrence of HCV after loss of virus specific CD4+ T cell response in acute hepatitis C by Gerlach (1999)10.1084/jem.178.1.17
/ J. Exp. Med. / Compartmentalization of T lymphocytes to the site of diseaseintrahepatic T cells specific for the NS4 protein of hepatitis C virus in patients with chronic hepatitis C by Minutello (1993)10.1111/j.1600-065X.1993.tb01517.x
/ Immunol. Rev. / Effector T-cell induction and T-cell memory versus peripheral deletion of T cells by Zinkernagel (1993)10.1038/nm0297-205
/ Nat. Med. / Antiviral pressure exerted by HIV-1 specific CTL during primary infection demonstrated by rapid selection of CTL escape virus by Borrow (1997)10.1126/science.279.5359.2103
/ Science. / Quantitation of HIV-1 specific CTL and plasma load of HIV-1 by Ogg (1998)10.1038/44385
/ Nature. / Two subsets of memory T lymphocytes with distinct homing potentials and effector functions by Sallusto (1999)10.1126/science.1833816
/ Science. / Separation of IL-4 production from proliferation by an altered peptide ligand by Evavold (1991)10.4049/jimmunol.152.10.4976
/ J. Immunol. / MHC class I and non-MHC-linked capacity for generating an anti-viral CTL response determines susceptibility to CTL exhaustion and establishment of virus persistence in mice by Moskophidis (1994)10.4049/jimmunol.163.6.3202
/ J. Immunol. / Selective retention of activated CD8+ T cells by the normal liver by Mehal (1999)10.1016/S0016-5085(99)70361-6
/ Gastroenterology. / HCV specific CD4+ T cellsdo they help or damage? by Naoumov (1999)10.1016/S0140-6736(05)60815-X
/ Lancet. / Can HCV infection be cleared? by Weiland (1998)10.1002/hep.510290118
/ Hepatology. / Detection of hepatitis C virus in paraffin-embedded liver biopsies of patients negative for viral RNA in serum by Dries (1999)10.1089/088922299310476
/ AIDS Res. Hum. Retroviruses. / Phenotypic analysis of CD8+ T lymphocytes in a cohort of HIV-1 infected patients treated with saquinavir, ritonavir and two nucleoside analogues for 1 year and association with plasma HIV-1 RNA by Kaufmann (1999)10.1128/JVI.73.8.6721-6728.1999
/ J. Virol. / Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy by Kalams (1999){'key': '2023072509175153400_R57', 'first-page': '904', 'article-title': 'Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levelsresults of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study', 'volume': '6', 'author': 'Giorgi', 'year': '1993', 'journal-title': 'J. Acquir. Immune Defic. Syndr.'}
/ J. Acquir. Immune Defic. Syndr. / Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levelsresults of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study by Giorgi (1993){'key': '2023072509175153400_R58', 'article-title': 'Life, activation and death of intra-hepatic lymphocytes in chronic viral hepatitis', 'volume': 'In press', 'author': 'Valiante', 'year': '2000', 'journal-title': 'Immunol. Rev'}
/ Immunol. Rev / Life, activation and death of intra-hepatic lymphocytes in chronic viral hepatitis by Valiante (2000)10.1172/JCI119778
/ J. Clin. Invest. / Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus by Chang (1997)10.1006/smvy.1996.0005
/ Semin. Virol. / Cytotoxic T cell antagonism in HIV by Klenerman (1996)10.1016/S0016-5085(98)70268-9
/ Gastroenterology. / Hepatitis C virus variants circumventing cytotoxic T lymphocyte activity as a mechanism of chronicity by Tsai (1998)10.1128/jvi.69.4.2187-2193.1995
/ J. Virol. / Immunobiology of cytotoxic T-cell escape mutants of lymphocytic choriomeningitis virus by Moskophidis (1995)10.1073/pnas.92.7.2755
/ Proc. Natl. Acad. Sci. USA. / Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant by Weiner (1995)
Dates
Type | When |
---|---|
Created | 23 years, 1 month ago (July 26, 2002, 12:48 p.m.) |
Deposited | 2 years, 1 month ago (July 25, 2023, 6:33 a.m.) |
Indexed | 6 days, 19 hours ago (Aug. 30, 2025, 12:41 p.m.) |
Issued | 25 years, 4 months ago (May 1, 2000) |
Published | 25 years, 4 months ago (May 1, 2000) |
Published Online | 25 years, 4 months ago (May 1, 2000) |
Published Print | 25 years, 4 months ago (May 1, 2000) |
@article{Lechner_2000, title={Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus}, volume={191}, ISSN={1540-9538}, url={http://dx.doi.org/10.1084/jem.191.9.1499}, DOI={10.1084/jem.191.9.1499}, number={9}, journal={The Journal of Experimental Medicine}, publisher={Rockefeller University Press}, author={Lechner, Franziska and Wong, David K.H. and Dunbar, P. Rod and Chapman, Roger and Chung, Raymond T. and Dohrenwend, Paul and Robbins, Gregory and Phillips, Rodney and Klenerman, Paul and Walker, Bruce D.}, year={2000}, month=may, pages={1499–1512} }